Idexx Laboratories (IDXX): are the analysts right?

Idexx Laboratories · Health Care · ref. ETF XLV · 50 calls · price $570.25
What the company does: IDEXX Laboratories, Inc. fabrique et vend des produits pour les vétérinaires animaux de compagnie, l'élevage et les tests d'eau.
📈 1-year price
$570.25+5.8% over range
Jul 8, 25low $514.61 · high $766.68Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 6 analysts

🎯 Analyst price target on IDXX

High target · 2 analysts$800+40.3%
Median target · 6 analysts$712.5+24.9%
Low target · 2 analysts$640+12.2%
Current price$570.25

🗳️ The analyst consensus

Analyst breakdown · 6 (6 months)
Strong Buy0%
Buy50%
Hold50%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on IDXX

Most reliable analysts on IDXX (% profitable · 365j · ≥2 calls)
Leerink Partners 100% +38.3% 2
Morgan Stanley 80% +30.6% 5
Barclays 50% +22.9% 4
JP Morgan 50% +6.5% 2

📊 What $1,000 invested in Idexx Laboratories would be worth

In short — $1,000 invested in Idexx Laboratories 10 years ago would be worth $7,219 today, i.e. +22%/yr on average. Best year: 2020 (+91%), worst: 2022 (-38%). Price performance, excluding dividends.

If I'd invested $1,000 in Idexx Laboratories

InvestmentWorth todayGain
1 years ago$1,273+27%
3 years ago$1,290+29%
5 years ago$1,053+5%
10 years ago$7,219+622%
since inception (1991)$580,931+57993%

Return by year (Idexx Laboratories)

YearReturn$1,000 invested at year start
2026 (YTD)-22%$778 (-22%)
2025+64%$1,273 (+27%)
2024-26%$948 (-5%)
2023+36%$1,290 (+29%)
2022-38%$800 (-20%)
2021+32%$1,053 (+5%)
2020+91%$2,016 (+102%)
2019+40%$2,830 (+183%)
2018+19%$3,366 (+237%)
2017+33%$4,489 (+349%)
2016+61%$7,219 (+622%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on IDXX

UBS
Apr 28, 26
■ Neutral neutral · not a buy · 🎯$640
Price at call : $553.66 — gap to target +16%
Today : $570.25 — gap to target +12%
🎯 on IDXX : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 28, 27
Citigroup
Apr 15, 26
■ Neutral neutral · not a buy · 🎯$650
Price at call : $569.95 — gap to target +14%
Today : $570.25 — gap to target +14%
🎯 on IDXX : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Apr 15, 27
Stifel
Mar 31, 26
▲ Buy · 🎯$675
Price at call : $564.66 — upside +20%
Today : $570.25 — upside +18%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Mar 31, 27
■ Neutral neutral · not a buy · 🎯$750
Price at call : $646.53 — gap to target +16%
Today : $570.25 — gap to target +32%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 9, 27
Barclays
Feb 5, 26
▲ Overweight · 🎯$800
Price at call : $644.61 — upside +24%
Today : $570.25 — upside +40%
🎯 on IDXX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 5, 27
UBS
Feb 3, 26
■ Neutral neutral · not a buy · 🎯$730
Price at call : $632.56 — gap to target +15%
Today : $570.25 — gap to target +28%
🎯 on IDXX : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 3, 27
BTIG
Feb 3, 26
▲ Buy · 🎯$800
Price at call : $632.56 — upside +26%
Today : $570.25 — upside +40%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 56.2% · +9.8% (112 calls)
in progress (365j)
matures : Feb 3, 27
Barclays
Dec 9, 25
▲ Overweight · 🎯$850
Price at call : $701.83 — upside +21%
Today : $570.25 — upside +49%
🎯 on IDXX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Dec 9, 26
▲ Overweight · 🎯$805
Price at call : $720.21 — upside +12%
Today : $570.25 — upside +41%
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Nov 4, 26
UBS
Nov 4, 25
■ Neutral neutral · not a buy · 🎯$750
Price at call : $720.21 — gap to target +4%
Today : $570.25 — gap to target +32%
🎯 on IDXX : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 4, 26
JP Morgan
Nov 4, 25
▲ Overweight · 🎯$775
Price at call : $720.21 — upside +8%
Today : $570.25 — upside +36%
🎯 on IDXX : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Nov 4, 26
BTIG
Nov 4, 25
▲ Buy · 🎯$830
Price at call : $722.12 — upside +15%
Today : $570.25 — upside +46%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 56.2% · +9.8% (112 calls)
in progress (365j)
matures : Nov 4, 26
Stifel
Oct 31, 25
▲ Buy · 🎯$700
Price at call : $629.51 — upside +11%
Today : $570.25 — upside +23%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Oct 31, 26
UBS
Oct 1, 25
■ Neutral neutral · not a buy · 🎯$720
Price at call : $620.11 — gap to target +16%
Today : $570.25 — gap to target +26%
🎯 on IDXX : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 1, 26
▲ Overweight · 🎯$765
Price at call : $650.84 — upside +18%
Today : $570.25 — upside +34%
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Aug 15, 26
Piper Sandler
Aug 11, 25
■ Neutral neutral · not a buy · 🎯$700
Price at call : $652.11 — gap to target +7%
Today : $570.25 — gap to target +23%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Aug 11, 26
JP Morgan
Aug 4, 25
▲ Overweight · 🎯$675
Price at call : $641.94 — upside +5%
Today : $570.25 — upside +18%
🎯 on IDXX : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Aug 4, 26
▲ Overweight · 🎯$722
Price at call : $641.94 — upside +12%
Today : $570.25 — upside +27%
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Aug 4, 26
▲ Overweight · 🎯$628
Price at call : $572.09 — upside +10%
Today : $570.25 — upside +10%
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jul 29, 26
▲ Outperform · 🎯$600
Price at call : $514.61 — upside +17%
Today : $570.25 — upside +5%
🎯 on IDXX : 100% (2 calls matureds) · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : Jul 17, 26
Stifel
Jul 2, 25
■ Hold neutral · not a buy · 🎯$540
Price at call : $547.01 — gap to target -1%
Today : $570.25 — gap to target -5%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Jul 2, 26
▲ Outperform · 🎯$580
Price at call : $526.92 — upside +10%
Today : $570.25 — upside +2%
Expected +10% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 100% (2 calls matureds) · 📊 on Health : 57.1% · +6.2% (35 calls)
+6.5%
stock +6% · XLV +12%
Stifel
May 19, 25
■ Hold neutral · not a buy · 🎯$510
Price at call : $517.16 — gap to target -1%
Today : $570.25 — gap to target -11%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : May 19, 26
▲ Overweight · 🎯$558
Price at call : $473.71 — upside +18%
Today : $570.25 — upside -2%
Expected +18% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+22.3%
stock +22% · XLV +8%
Stifel
May 1, 25
■ Hold neutral · not a buy · 🎯$460
Price at call : $471.38 — gap to target -2%
Today : $570.25 — gap to target -19%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : May 1, 26
■ Neutral neutral · not a buy · 🎯$475
Price at call : $421.59 — gap to target +13%
Today : $570.25 — gap to target -17%
🎯 on IDXX : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Apr 21, 26
▲ Overweight · 🎯$548
Price at call : $402.38 — upside +36%
Today : $570.25 — upside -4%
Expected +36% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+41.6%
stock +42% · XLV +8%
Stifel
Apr 14, 25
■ Hold neutral · not a buy · 🎯$420
Price at call : $404.02 — gap to target +4%
Today : $570.25 — gap to target -26%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Apr 14, 26
Stifel
Feb 28, 25
■ Hold neutral · not a buy · 🎯$450
Price at call : $437.11 — gap to target +3%
Today : $570.25 — gap to target -21%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 28, 26
Piper Sandler
Feb 10, 25
■ Neutral neutral · not a buy · 🎯$510
Price at call : $463.74 — gap to target +10%
Today : $570.25 — gap to target -11%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 10, 26
▲ Overweight · 🎯$559
Price at call : $468.55 — upside +19%
Today : $570.25 — upside -2%
Expected +19% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+37.4%
stock +37% · XLV +4%
Barclays
Feb 4, 25
▲ Overweight · 🎯$520
Price at call : $465.03 — upside +12%
Today : $570.25 — upside -9%
Expected +12% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+38.3%
stock +38% · XLV +6%
■ Neutral neutral · not a buy · 🎯$535
Price at call : $465.03 — gap to target +15%
Today : $570.25 — gap to target -6%
🎯 on IDXX : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Feb 4, 26
Stifel
Feb 3, 25
■ Hold neutral · not a buy · 🎯$460
Price at call : $469.04 — gap to target -2%
Today : $570.25 — gap to target -19%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 3, 26
▲ Overweight · 🎯$550
Price at call : $423.99 — upside +30%
Today : $570.25 — upside -4%
Expected +30% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+58.1%
stock +58% · XLV +5%
▲ Outperform · 🎯$500
Price at call : $430.77 — upside +16%
Today : $570.25 — upside -12%
Expected +16% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 100% (2 calls matureds) · 📊 on Health : 57.1% · +6.2% (35 calls)
+70.1%
stock +70% · XLV +5%
■ Neutral neutral · not a buy · 🎯$435
Price at call : $415.98 — gap to target +5%
Today : $570.25 — gap to target -24%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 4, 25
Barclays
Nov 4, 24
▲ Overweight · 🎯$481
Price at call : $414.52 — upside +16%
Today : $570.25 — upside -16%
Expected +16% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+74.2%
stock +74% · XLV -1%
JP Morgan
Oct 11, 24
▲ Overweight · 🎯$575
Price at call : $478 — upside +20%
Today : $570.25 — upside +1%
Expected +20% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
+32.5%
stock +32% · XLV -8%
Stifel
Oct 10, 24
■ Hold neutral · not a buy · 🎯$500
Price at call : $476.27 — gap to target +5%
Today : $570.25 — gap to target -12%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Oct 10, 25
Piper Sandler
Aug 14, 24
■ Neutral neutral · not a buy · 🎯$520
Price at call : $485.52 — gap to target +7%
Today : $570.25 — gap to target -9%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Aug 14, 25
BTIG
Jul 25, 24
▲ Buy · 🎯$580
Price at call : $469.71 — upside +23%
Today : $570.25 — upside +2%
Expected +23% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 56.2% · +9.8% (112 calls)
+20.6%
stock +21% · XLV -10%
Stifel
Jun 24, 24
■ Hold neutral · not a buy · 🎯$510
Price at call : $491.49 — gap to target +4%
Today : $570.25 — gap to target -11%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Jun 24, 25
▲ Overweight · 🎯$596
Price at call : $548.53 — upside +9%
Today : $570.25 — upside +5%
Expected +9% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 80% (5 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
-6.7%
stock -7% · XLV -11%
Barclays
May 2, 24
▲ Overweight · 🎯$570
Price at call : $480.6 — upside +19%
Today : $570.25 — upside -0%
Expected +19% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-1.1%
stock -1% · XLV -2%
JP Morgan
Feb 6, 24
▲ Overweight · 🎯$630
Price at call : $572.31 — upside +10%
Today : $570.25 — upside +10%
Expected +10% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
-19.5%
stock -20% · XLV +2%
Barclays
Feb 6, 24
▲ Overweight · 🎯$655
Price at call : $572.31 — upside +14%
Today : $570.25 — upside +15%
Expected +14% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-19.5%
stock -20% · XLV +2%
Piper Sandler
Jan 30, 24
■ Neutral neutral · not a buy · 🎯$525
Price at call : $521.03 — gap to target +1%
Today : $570.25 — gap to target -8%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jan 29, 25
Goldman Sachs
Jan 17, 24
▲ Buy · 🎯$650
Price at call : $525.28 — upside +24%
Today : $570.25 — upside +14%
Expected +24% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 0% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)
-20.2%
stock -20% · XLV +1%
▲ Overweight · 🎯$525
Price at call : $422.47 — upside +24%
Today : $570.25 — upside -8%
Expected +24% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
+0.2%
stock +0% · XLV +15%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)